Physiological principles of endocrine replacement: estrogen.

Area of Science:

• Endocrinology
• Reproductive Biology
• Menopause Research

Background:

• Estradiol (E2) is the principal biologically active estrogen in both sexes, synthesized in ovarian granulosa and testicular Leydig cells.
• E2 formation involves testosterone aromatization, with adipose tissue being a key site for extra-gonadal estrogen production.
• Loss of ovarian function, whether through hypogonadism or premature ovarian failure, drastically reduces circulating E2, impacting reproductive health.

Purpose of the Study:

• To review the sources and significance of circulating estradiol (E2).
• To outline the severe consequences of estrogen depletion due to ovarian function loss.
• To discuss current and potential hormone replacement therapy strategies for managing E2 deficiency.

Main Methods:

• Literature review of estrogen synthesis, metabolism, and physiological roles.
• Analysis of clinical consequences associated with decreased estradiol levels.
• Evaluation of various hormone replacement therapy regimens.

Main Results:

• Ovarian function loss, particularly at menopause, causes a ~90% reduction in circulating E2.
• Estrogen deficiency leads to symptoms like hot flashes, bone loss (osteoporosis), and increased cardiovascular disease risk.
• Hormone replacement therapy, primarily with estrogen and progestogen, is effective for symptom management and mitigating long-term health risks.

Conclusions:

• Estradiol is crucial for reproductive health and overall well-being.
• Estrogen depletion has significant adverse health consequences, including osteoporosis and cardiovascular risks.
• Hormone replacement therapy is a pragmatic approach to manage E2 deficiency and its associated health issues.